ARCA biopharma (ABIO) executive Ozeroff bought 50,000 shares for $113K at $2.26
Insider transactions reported
Christopher David Ozeroff (executive at ARCA biopharma Inc., ABIO) reported that they bought 50,000 shares for $113K at $2.26 on Nov 22, 2021. After these transactions the filing shows 50,970 shares held directly.
- Reporting person
- Ozeroff Christopher David
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Nov 22, 2021 | Open-market purchase (P) | Common Stock1 | +50,000 | $2.26 | $113K | 50,970 direct |
Holdings before and after
- Common Stock: 970 to 50,970 direct
Footnotes from the filing
- 1. The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $2.21 to $2.329. Upon request of the SEC staff, ARCA biopharma, Inc. (the Company ) or a security holder of the Company, the reporting person will provide full information regarding the number of shares purchased at each separate price.
Transaction codes in this filing
- Open-market purchase:
- Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
FAQ
What did Ozeroff report in this ABIO Form 4?
Christopher David Ozeroff (executive at ARCA biopharma Inc., ABIO) reported that they bought 50,000 shares for $113K at $2.26 on Nov 22, 2021. After these transactions the filing shows 50,970 shares held directly.
How many ABIO shares does Ozeroff hold after this filing?
The filing shows 50,970 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code P mean on an SEC Form 4?
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
Historical context for ABIO
Earlier insider filings at ABIO
- May 13, 2021SEC Form 4: CONWAY ROBERT E bought $31,947 worth of Common Stock (10,000 units at $3.19), increasing direct ownership by 25% to 50,000 units
- May 6, 2021SEC Form 4: CONWAY ROBERT E bought $32,345 worth of Common Stock (10,000 units at $3.23), increasing direct ownership by 33% to 40,000 units
Keep researching ABIO
- ABIO insider tradesEvery buy and sale reported by ARCA biopharma Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
Follow ABIO and get a push notification the moment its next story breaks.